FindTrial
Sign In

Research on Multi-parameter MRI and Texture Analysis in Risk Assessment of Endometrial Cancer

Research on Multiparameter MRI and Texture Analysis in FIGO Staging, Pathological Classification, Grading, Immunohistochemical Expression and Efficacy Prediction of Endometrial Cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043892
Enrollment
Unknown
Registered
2021-03-04
Start date
2021-04-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Gold Standard:Puncture biopsy or postoperative pathology
Index test:Tumor&#32
size,&#32
pathological&#32
type,&#32
grade,&#32
differentiation&#32
and&#32
immunohistochemical&#32
expression

Sponsors

Imaging Department of Anhui Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 85 Years

Inclusion criteria

Inclusion criteria: First diagnosed patients with endometrial carcinoma.

Exclusion criteria

Exclusion criteria: Patients who have contraindications for MRI scanning or do not accept observation trial.

Design outcomes

Primary

MeasureTime frame
Intravoxel incoherent motion diffusion weighted imaging;—

Countries

China

Contacts

Public ContactDong Jiangning

Imaging Department of Anhui Cancer Hospital

dongjn@163.com+86 13665516198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026